IREN (IREN) Q1 2027 Earnings Call Transcript

IREN reported September-quarter revenue of $228 million, up 66% sequentially, as AI cloud revenue climbed 182% to $200 million; adjusted EBITDA was $66 million, with a 29% margin versus 14% in the prior quarter, while the company recorded a $263 million net loss. Operating ARR doubled sequentially to $1 billion and backlog exceeded $20 billion, but the target for more than $4 billion of ARR shifted to January 2027, with a possible delay to February depending on supplier timing. IREN plans approximately $15 billion of CapEx for the remainder of fiscal 2027 and said it will pace spending amid more selective capital markets.

Analysis

The key underwriting variable is conversion, not demand: backlog and ARR only create equity value once capacity is commissioned, accepted, financed and earning returns after depreciation and funding costs. The reported AI gross margin excludes D&A, while the net loss and planned spend underscore that the asset-replacement and capital burden is still material. Do not capitalize headline ARR as if it were contracted free cash flow.

Near term, the January-to-February commissioning window is a binary credibility test. Supplier slippage or further customer design changes could delay revenue recognition while operating costs rise; delivery would instead validate IREN’s integrated build-and-operate model and improve financing options. Over 1–3 months, watch commissioned MW, recognized revenue versus ARR, GPU-financing terms, customer prepayments actually received, and whether the remaining fiscal-year funding gap is closed without expensive equity. Over 6–18 months, the upside depends on repeated deployments and positive returns after GPU depreciation—not merely high utilization or contract pricing.

The contrarian point is two-sided: selective capital markets may be discounting a real asset base and IREN’s ability to pace projects, but management’s financing flexibility is not the same as committed funding. Contract concentration and supplier bottlenecks make backlog quality insufficient protection against a delay. Microsoft benefits from additional compute only if delivery is reliable; NVIDIA benefits from deployment demand, though tighter memory and component supply can raise system costs across the ecosystem. Verify financing commitments and contract cancellation/acceptance terms before treating the backlog as bankable cash flow.

Key Decisions for Investors

• Keep IREN on a catalyst watchlist rather than buying the backlog narrative outright. Reassess after the >$4B ARR commissioning milestone: confirmation by January supports the execution case; a slip toward end-February is a warning, and further slippage or weaker funding terms invalidates it.
• For a relative-value expression, consider long NVDA / short IREN only if IREN’s commissioning slips or funding costs worsen while GPU demand remains intact. NVDA is not a hedge for broad AI-capex weakness; size the pair to limit exposure to that common factor.
• Track the funding bridge as a hard gate: verify sources for the approximately $6B remaining planned CapEx after stated cash and commitments, including whether prospective asset financing is binding and at what cost. If this depends on equity issuance or materially higher-cost debt, reduce exposure rather than extrapolating management’s illustrative paybacks.
• Do not infer consolidated profitability from 86% AI cloud gross margin or the $20B backlog. Monitor recognized revenue, cash operating costs, D&A, interest expense and GPU payback after customer prepayments; deteriorating unit economics would falsify the bullish conversion thesis.